Skip to main content

Table 1 Baseline characteristics stratified by the tertile of VFA

From: Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset

Variables

T1

(11.50–95.80)

T2

(95.90-153.10)

T3

(153.20-375.60)

P-value

N

1978

1981

1985

 

Sex, n (%)

   

< 0.001

Female

1659 (83.87)

1133 (57.19)

353 (17.78)

 

Male

319 (16.13)

848 (42.81)

1632 (82.22)

 

Ethnic group, n (%)

   

0.078

Non-han

36 (1.82)

25 (1.26)

20 (1.01)

 

Han

1942 (98.18)

1956 (98.74)

1965 (98.99)

 

Marital status, n (%)

   

< 0.001

Unmarried

148 (7.54)

32 (1.66)

21 (1.10)

 

Married

1814 (92.46)

1900 (98.34)

1891 (98.90)

 

Age, years, n (%)

   

< 0.001

< 40

446 (22.55)

159 (8.03)

122 (6.15)

 

>=40, < 60

1277 (64.56)

1219 (61.53)

1013 (51.03)

 

>=60

255 (12.89)

603 (30.44)

850 (42.82)

 

Current smoking, n (%)

   

< 0.001

No

1774 (89.69)

1661 (83.85)

1556 (78.39)

 

Yes

204 (10.31)

320 (16.15)

429 (21.61)

 

Current drinking, n (%)

   

< 0.001

No

1869 (94.49)

1762 (88.94)

1538 (77.48)

 

Yes

109 (5.51)

219 (11.06)

447 (22.52)

 

BMI, kg/m2

20.80 ± 1.69

22.13 ± 1.29

22.73 ± 1.11

< 0.001

Waist, cm

73.85 ± 5.88

79.48 ± 5.72

85.81 ± 5.19

< 0.001

SBP, mmHg

117.62 ± 17.58

125.86 ± 18.83

131.25 ± 18.69

< 0.001

DBP, mmHg

68.76 ± 10.78

72.76 ± 11.08

76.10 ± 11.11

< 0.001

TP, g/L

71.71 ± 3.97

71.73 ± 4.16

71.76 ± 4.09

0.937

ALT, U/L

14.30 (11.12,19.10)

17.20 (13.10,23.20)

19.40 (14.60,25.83)

< 0.001

AST, U/L

20.24 ± 7.64

21.54 ± 7.92

22.60 ± 18.40

< 0.001

Cre, µmol/L

62.03 ± 11.00

66.79 ± 14.96

74.25 ± 16.90

< 0.001

BUN, mmol/L

4.73 ± 1.15

5.08 ± 1.36

5.43 ± 1.46

< 0.001

eGFR, mL/min/1.73m2

97.28 ± 18.72

94.68 ± 18.36

93.51 ± 19.51

< 0.001

TC, mmol/L

4.96 ± 0.89

4.81 ± 1.08

5.01 ± 0.99

< 0.001

LDL-C, mmol/L

2.68 ± 0.70

2.77 ± 0.87

2.85 ± 0.81

< 0.001

TG, mmol/L

1.10 ± 0.58

1.44 ± 0.82

1.71 ± 1.08

< 0.001

HDL-C, mmol/L

1.59 ± 0.32

1.43 ± 0.29

1.30 ± 0.27

< 0.001

FBG, mmol/L

4.93 ± 0.63

5.20 ± 1.08

5.60 ± 1.57

< 0.001

VFA, cm2

132.72 ± 29.71

196.75 ± 13.89

245.27 ± 14.76

< 0.001

SFA, cm2

83.89 ± 34.89

92.49 ± 35.10

98.96 ± 34.85

< 0.001

TFA, cm2

149.21 ± 47.87

221.66 ± 38.49

296.31 ± 55.05

< 0.001

VFA/SFA

0.95 ± 0.69

1.44 ± 0.63

2.46 ± 1.01

< 0.001

MetS, n (%)

   

< 0.001

No

1952 (98.69)

1799 (90.81)

1290 (64.99)

 

Yes

26 (1.31)

182 (9.19)

695 (35.01)

 
  1. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TP, total protein; ALT, alanine aminotransferase; AST, aspartate transaminase; Cre, Creatinine; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; VFA, visceral fat area; SFA, subcutaneous fat area; TFA, total fat area; MetS, metabolic syndrome. OR, odds ratio; CI, confidence interval. Except for ALT, which are expressed as medians (upper and lower quartiles), all other continuous variables are expressed as mean ± standard deviation, and categorical variables are expressed as counts (%). For categorical variables, reference groups are as indicated. For continuous variables, OR represent the risk per unit increase
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X